DexCom, Inc. (DXCM) Q3 2026 earnings results

DexCom, Inc. (DXCM) reported Q3 2026 results on Oct 29, 2026, 4:03:50 PM ET: adjusted EPS $0.73 vs. $0.67 expected (beat by 8.3%); revenue $1.34B vs. $1.33B expected (beat by 1.3%). Outlook: Dexcom raised its full-year 2026 revenue guidance to $5.20 - $5.25 billion.

MetricReportedAnalyst estimateResult
EPS (adjusted, diluted)$0.73$0.67Beat by 8.3%
Revenue$1.34B$1.33BBeat by 1.3%

Analyst estimate: the average forecast before the release.

Source

Figures from the SEC 8-K filing, released Oct 29, 2026, 4:03:50 PM ET. Nexqual published them 43 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.

Year over year

Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 11.2% from $1.21B.

Stock reaction

The results came out after the market closed. DXCM closed at $79.93 on October 29, 2026, before the results. The first trading session after the release is Friday, October 30, 2026; this page shows the reaction once trading starts (pre-market and after-hours prices are not included).

Questions and answers

Did DexCom, Inc. beat earnings expectations?

Yes. DexCom, Inc. reported adjusted EPS of $0.73 against an average analyst estimate of $0.67 (beat by 8.3%), and revenue of $1.34B against $1.33B expected (beat by 1.3%).

What were DexCom, Inc.'s Q3 2026 earnings and revenue?

adjusted diluted EPS of $0.73 and revenue of $1.34B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 11.2% from $1.21B.

When did DexCom, Inc. report Q3 2026 earnings?

Oct 29, 2026, 4:03:50 PM ET, in an SEC 8-K filing (Item 2.02).

How did DXCM stock react to the earnings?

The results came out after the market closed. DXCM closed at $79.93 on October 29, 2026, before the results. The first trading session after the release is Friday, October 30, 2026; this page shows the reaction once trading starts (pre-market and after-hours prices are not included).

What did DexCom, Inc. say about its outlook?

Dexcom raised its full-year 2026 revenue guidance to $5.20 - $5.25 billion.

More on DXCM

DXCM stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 29, 2026.

Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:07 UTC. Not investment advice.

Data source: Nexqual. Last updated: October 29, 2026 at 23:07 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt